Novel Automated Stem Cell High Content Screening Platform
A new technical poster, available from Agilent Automation Solutions, describes how researchers at I-STEM (Evry, France) have used a BioCel 1800 platform to automate high content screening of small molecules for muscular dystrophy therapeutic research.
[Read the full article here]Related News:
Stemina Taps Agilent Tools for Stem Cell Metabolite Biomarker Discovery
UBC-led team develops platform to monitor hematopoietic stem cells
High-Density Microwell Chip for Culture and Analysis of Stem Cells